Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

93.11 -1.62 (-1.71%)
Official Closing Price Updated: 7:00 PM EDT, Mar 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 68,436,384
Open 94.58
Bid (Size) 93.30 (80)
Ask (Size) 94.80 (1)
Prev. Close 94.73
Today's Range 93.07 - 94.68
52wk Range 81.04 - 134.63
Shares Outstanding 2,531,374,696
Dividend Yield 3.31%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Which Is The Healthiest Investment: Merck Or Pfizer
Adeep dive into Merck and Pfizer, two of the biggest pharmaceutical companies out there. 
Via Talk Markets
Topics Stocks / Equities
Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
UK pharma leaders warn excessive NHS levies threaten industry growth, urging the government to reform payments. The ABPI highlights declining UK R&D investment and falling global competitiveness. 
Via Benzinga

Performance

YTD
-6.1%
-6.1%
1 Month
+8.8%
+8.8%
3 Month
-5.0%
-5.0%
6 Month
-20.5%
-20.5%
1 Year
-24.7%
-24.7%

More News

Read More
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against FMC, TransMedics, Alarum, and Merck and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Merck & Co Unusual Options Activity For March 10
Via Benzinga
ROSEN, LEADING INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK
From The Rosen Law Firm PA
Via GlobeNewswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co.
From Faruqi & Faruqi LLP
Via GlobeNewswire
Merck Data at ACC.25 Highlight Innovative Advancements and Commitment to Improving Outcomes for People Living with Cardiovascular Disease
From Merck & Co., Inc.
Via Business Wire
Merck & Co's Options: A Look at What the Big Money is Thinking
Via Benzinga
Pliant Therapeutics' Investigational Cancer Drug Shows Antitumor Activity Across Multiple Tumor Types
Via Benzinga
Why MERCK & CO. INC. (NYSE:MRK) qualifies as a good dividend investing stock.
Via Chartmill
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
Via The Motley Fool
Topics Stocks
Exposures US Equities
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co.
From Faruqi & Faruqi LLP
Via GlobeNewswire
A Closer Look at Merck & Co's Options Market Dynamics
Via Benzinga
These S&P500 stocks are gapping in today's session
Via Chartmill
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK
From The Rosen Law Firm PA
Via GlobeNewswire
Inflation Isn’t Going Away, But These Sectors Don’t Care
Via Talk Markets
Topics ETFs Economy Stocks / Equities
Exposures Interest Rates
How Do Investors Really Feel About Merck & Co?
Via Benzinga
Merck Plans Regulatory Submission For Two-Drug Regime For HIV Infection By Mid-2025
Via Benzinga
Merck Announces Positive Data from Phase 3 Trials that Show the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir (DOR/ISL) Maintained HIV-1 Viral Suppression at Week 48
From Merck & Co., Inc.
Via Business Wire
Merck Injects $1 Billion To Expand Vaccine Production In US
Via Benzinga
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co.
From Faruqi & Faruqi LLP
Via GlobeNewswire
Moderna: 4 Key Reasons the CEO Just Bought $5M in Shares
Via MarketBeat
Merck Unveils New Facility to Increase Vaccine Production Capacity
From Merck & Co., Inc.
Via Business Wire
MERCK & CO., INC. (NYSE: MRK) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Merck & Co., Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
Institutional Investors Bet $1B on These 4 Stocks—Should You?
Via MarketBeat

Frequently Asked Questions

Is Merck & Co publicly traded?
Yes, Merck & Co is publicly traded.
What exchange does Merck & Co trade on?
Merck & Co trades on the New York Stock Exchange
What is the ticker symbol for Merck & Co?
The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
What is the current price of Merck & Co?
The current price of Merck & Co is 93.11
When was Merck & Co last traded?
The last trade of Merck & Co was at 03/21/25 07:00 PM ET
What is the market capitalization of Merck & Co?
The market capitalization of Merck & Co is 235.70B
How many shares of Merck & Co are outstanding?
Merck & Co has 236B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.